首页> 外文期刊>The Internet Journal of Surgery >Bilateral versus Posterior Injection of Botulinum Toxin in the Internal Anal Sphincter for the Treatment of Acute Anal Fissure
【24h】

Bilateral versus Posterior Injection of Botulinum Toxin in the Internal Anal Sphincter for the Treatment of Acute Anal Fissure

机译:肛内括约肌双侧与后路注射肉毒杆菌毒素治疗急性肛裂

获取原文
获取外文期刊封面目录资料

摘要

Aim: Comparison of bilateral versus posterior injection of botulinum toxin in the internal anal sphincter for treatment of acute anal fissure and prevention of chronicity.Methods: Forty patients with acute anal fissure were randomly divided into two equal groups. Group I patients were treated by injecting 20 units of Botulinum toxin on each lateral side of the internal anal sphincter. Group II patients were treated by injecting 25 units of Botulinum toxin in the midline posteriorly.Results: Mean period for pain relief was 8.45±7.41 days in group I and 7.20±7.19 days in group II. Mean time of healing was 5.20 ±1.85 weeks in group I and 5.40 ±2.01 weeks in group II. Two patients (10%) in group I and 3 patients (15%) in group II showed no healing. Fissure recurred to 4 patients (20%) in group I and 3 patients (15%) in group II.Conclusion: Botulinum toxin injection is effective in treating acute anal fissure and preventing chronicity. A single posterior injection is easier, less painful and as effective as bilateral injection in pain relief. Introduction Anal fissure is a common, painful condition that causes significant morbidity mostly in young adults. It is a split in the skin of the distal anal canal. The classic symptoms are intense pain on or after defecation and anal bleeding [1]. Anal fissures are nearly always single, and they have predilection for the posterior midline location and less commonly for the anterior midline where one of ten fissures is located [2].Anal fissure is clinically differentiated into acute and chronic. The point at which an acute fissure becomes chronic is contentious, but published work suggests symptoms lasting for more than two months are undeniably chronic [3].Most anal fissures are caused by stretching of the anal mucosa beyond its capability. Many acute anal fissures will heal spontaneously or by medical treatment. Recurrence rates range from 30-70% if treatment is abandoned after the fissure is healed [4]. Some fissures become chronic and will not heal. The most common cause for this is spasm of the internal anal sphincter muscle. This spasm causes poor blood flow to the anal mucosa, hence producing an ulcer which does not heal since it is deprived of normal blood supply [5].Aggressive treatment of acute anal fissure with the recently named chemical sphincterotomy may prevent its evolution to chronicity.The aim of this study is to evaluate the efficacy of injection of Botulinum toxin into the internal anal sphincter for treatment of acute anal fissure and prevention of chronicity and to compare two sites of injection of Botulinum toxin; bilateral versus posterior. Patients And Methods This study was performed in the General Surgery Department, Ghodran General Hospital, KSA, during the period from October 2005 to February 2008 on 40 patients with acute posterior anal fissure randomly divided through computer randomization program (www.randomization.com) into two equal groups. Patients having other anal pathology (i.e., inflammatory bowel diseases, hemorrhoids, anal fistula or anal abscess) were excluded from this study. Full explanation of procedures and patient consent were assured before inclusion in the research. The study protocol was approved by the Ethics Committee of Ghodran General Hospital, KSA.Group I patients were treated by injection of Botulinum toxin into the internal sphincter. The 100 units’ vials of type A lyophilized Botulinum toxin (Botox, Allergan, Inc, Irvine, CA, USA) were diluted in saline to a concentration of 50 units per milliliter immediately before injection. With a 25-G needle, 20 units were injected on each side of the internal sphincter guided under direct vision and digital examination (a total of 40 units per patient). No sedation or local anesthesia was used during the procedure.Group II patients were treated by a single injection of 25 units of Botulinum toxin with a 25-G needle into the internal sphincter in the midline posteriorly under direct vision and d
机译:目的:比较肛门内括约肌双侧和后侧注射肉毒杆菌毒素治疗急性肛裂和预防慢性病的方法。方法:将40例急性肛裂患者随机分为两组。第一组患者通过在肛门内括约肌的每个侧面注射20单位肉毒杆菌毒素进行治疗。第二组患者在中线后方注射25单位肉毒杆菌毒素。结果:第一组平均缓解疼痛时间为8.45±7.41天,第二组为7.20±7.19天。 I组的平均愈合时间为5.20±1.85周,II组的平均愈合时间为5.40±2.01周。 I组中的2名患者(10%)和II组中的3名患者(15%)没有愈合。 Ⅰ组4例(20%),Ⅱ组3例(15%)复发。结论:肉毒杆菌毒素注射可有效治疗急性肛裂和预防慢性。单一后路注射更容易,痛苦更少,并且在缓解疼痛方面与双侧注射一样有效。引言肛裂是一种常见的痛苦状况,主要在年轻人中引起明显的发病率。它是远端肛管皮肤的裂痕。典型的症状是排便时或之后剧烈疼痛和肛门出血[1]。肛裂几乎总是单一的,并且它们偏向于后中线的位置,而偏向于前中线(十个裂口之一所在的位置)[2]。肛门裂在临床上分为急性和慢性两种。急性裂缝变为慢性的观点尚有争议,但已发表的研究表明,持续超过两个月的症状无可否认是慢性的[3]。大多数肛门裂缝是由肛门粘膜伸展超出其能力所致。许多急性肛裂会自发或通过药物治疗。如果裂痕愈合后放弃治疗,复发率范围为30-70%[4]。有些裂痕会变成慢性裂痕,并且无法he愈。最常见的原因是肛门内括约肌痉挛。这种痉挛导致肛门粘膜的血流不畅,从而导致溃疡,因为它失去了正常的血液供应而无法愈合[5]。用最近命名的化学括约肌切开术积极治疗急性肛裂可能会阻止其发展为慢性。这项研究的目的是评估向内部肛门括约肌注射肉毒杆菌毒素治疗急性肛裂和预防慢性病的功效,并比较注射肉毒杆菌毒素的两个部位。双侧vs后侧。患者与方法本研究在2005年10月至2008年2月期间,在KSA Ghodran总医院的普外科中,对40例急性后肛门裂患者通过计算机随机程序(www.randomization.com)随机分为两组。两个相等的组。患有其他肛门病变(即肠炎,痔疮,肛瘘或肛门脓肿)的患者被排除在本研究之外。在纳入研究之前,应确保对程序和患者同意书有充分的解释。该研究方案得到了KSA Ghodran总医院伦理委员会的批准。第一类患者通过向内部括约肌注射肉毒杆菌毒素进行治疗。注射前,将100单位的A型冻干肉毒杆菌毒素瓶(Botox,Allergan,Inc,Irvine,CA,美国)稀释到盐水中,使其浓度为每毫升50单位。用25 G针在直视和数字检查的引导下,在内部括约肌的每一侧注射20个单位(每位患者总共40个单位)。手术过程中未使用镇静剂或局部麻醉剂。第二组患者在直视和d直视下向中线内括约肌内单次注射25单位的25G针肉毒杆菌毒素

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号